{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:38:19Z","timestamp":1779881899258,"version":"3.53.1"},"reference-count":49,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stabilized vitiligo resistant to conventional therapy (e.g. segmental vitiligo) and piebaldism lesions can be treated with autologous cellular grafting techniques, such as non\u2010cultured cell suspension transplantation (NCST) and cultured melanocyte transplantation (CMT). These methods are preferred when treating larger surface areas due to the small amount of donor skin needed. However, the donor to recipient expansion ratios and outcomes reported in studies with cellular grafting vary widely, and to date, no overview or guideline exists on the optimal ratio. The aim of our study was to obtain an overview of the various expansion ratios used in cellular grafting and to identify whether expansion ratios affect repigmentation and colour match. We performed a systematic literature search in MEDLINE and EMBASE to review clinical studies that reported the expansion ratio and repigmentation after cellular grafting. We included 31 eligible clinical studies with 1591 patients in total. Our study provides an overview of various expansion ratios used in cellular grafting for vitiligo and piebaldism, which varied from 1:1 up to 1:100. We found expansion ratios between 1:1 and 1:10 for studies investigating NCST and from 1:20 to 1:100 in studies evaluating CMT. Pooled analyses of studies with the same expansion ratio and repigmentation thresholds showed that when using the lowest (1:3) expansion ratio, the proportion of lesions achieving &gt;50% or &gt;75% repigmentation after NCST was significantly better than when using the highest (1:10) expansion ratio (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> <jats:italic>P<\/jats:italic>\u00a0=\u00a00.000 and <jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> <jats:italic>P<\/jats:italic>\u00a0=\u00a00.006, respectively). Less than half of our included studies stated the colour match between different expansion ratios, and results were variable. In conclusion, the results of our study indicate that higher expansion ratios lead to lower repigmentation percentages after NCST treatment. This should be taken into consideration while determining which expansion ratio to use for treating a patient.<\/jats:p>","DOI":"10.1111\/jdv.17108","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T06:14:36Z","timestamp":1610691276000},"page":"1077-1086","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review"],"prefix":"10.1111","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4328-1132","authenticated-orcid":false,"given":"V.S.","family":"Narayan","sequence":"first","affiliation":[{"name":"Department of Dermatology Amsterdam University Medical Center Netherlands Institute for Pigment Disorders Amsterdam Infection and Immunity Institute Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.L.C.","family":"van den Bol","sequence":"additional","affiliation":[{"name":"Department of Dermatology Amsterdam University Medical Center Netherlands Institute for Pigment Disorders Amsterdam Infection and Immunity Institute Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-8195","authenticated-orcid":false,"given":"N.","family":"van Geel","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ghent University Hospital Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Bekkenk","sequence":"additional","affiliation":[{"name":"Department of Dermatology Amsterdam University Medical Center Netherlands Institute for Pigment Disorders Amsterdam Infection and Immunity Institute Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Luiten","sequence":"additional","affiliation":[{"name":"Department of Dermatology Amsterdam University Medical Center Netherlands Institute for Pigment Disorders Amsterdam Infection and Immunity Institute Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wolkerstorfer","sequence":"additional","affiliation":[{"name":"Department of Dermatology Amsterdam University Medical Center Netherlands Institute for Pigment Disorders Amsterdam Infection and Immunity Institute Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.03.022"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01369.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12532"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10014.x"},{"key":"e_1_2_6_6_1","first-page":"2","article-title":"Surgical therapies for vitiligo","volume":"35","author":"Tf M","year":"2017","journal-title":"Dermatol Clin"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1179251"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.12.1543"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2008.00528.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03824.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.1999.tb00510.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.53194"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"e_1_2_6_14_1","first-page":"l4898","article-title":"Revised Cochrane risk\u2010of\u2010bias tool for randomized trials (RoB 2)","volume":"366","author":"Higgins P","year":"2019","journal-title":"RoB 2.o Dev Gr"},{"key":"e_1_2_6_15_1","first-page":"1","volume-title":"Checklist for Case Series. Joanna Briggs Inst Crit Apprais tools use JBI Syst Rev","author":"Joanna Briggs Institute","year":"2017"},{"key":"e_1_2_6_16_1","first-page":"1","volume-title":"Checklist for quasi\u2010experimental studies","author":"The Joanna Briggs Institute","year":"2014"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02403.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12759"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14950"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000962"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5795"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12007"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.05.002"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.02226.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175700"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4919"},{"key":"e_1_2_6_27_1","first-page":"1203","article-title":"Double\u2010blind placebo\u2010controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo","volume":"140","author":"Geel N","year":"2004","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15569"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1034-7"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2011.04065.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10398.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1034068"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2013.09.004"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.18942"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03759.x"},{"key":"e_1_2_6_36_1","first-page":"1211","article-title":"Long\u2010term follow\u2010up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte\u2010keratinocyte cell transplantation","volume":"140","author":"Sv M","year":"2004","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_37_1","first-page":"32","article-title":"Autologous noncultured melanocyte\u2010keratinocyte transplantation in stable vitiligo: A randomized comparative study of recipient site preparation by two techniques","volume":"85","author":"Gupta S","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02177.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.10.007"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.158439"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001641"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.4103\/JCAS.JCAS_119_16"},{"key":"e_1_2_6_44_1","first-page":"536","article-title":"Stable vitiligo treated by a combination of low\u2010dose oral pulse betamethasone and autologous, noncultured melanocyte\u2010keratinocyte cell transplantation","volume":"32","author":"Sv M","year":"2006","journal-title":"Dermatol Surg"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01628.x"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001190"},{"key":"e_1_2_6_47_1","first-page":"1032","article-title":"Treatment of vitiligo with a melanocyte\u2010keratinocyte cell suspension versus dermabrasion only: A pilot study with a 12\u2010month follow up","volume":"10","author":"V\u00e1zquez\u2010Mart\u00ednez OT","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_546_19"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14286"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12674"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.17108","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.17108","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.17108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:03:23Z","timestamp":1693335803000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.17108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1111\/jdv.17108"],"URL":"https:\/\/doi.org\/10.1111\/jdv.17108","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"2020-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}